1st Annual International Congress on Oncology Pathology : Towards Harmonization of Pathology and Oncology Standards

1st Annual International Congress on Oncology Pathology : Towards Harmonization of Pathology and Oncology Standards is organized by Physicians Education Resource, LLC (PER) and would be held during Jun 24, 2017 at The Westin New York at Times Square, New York, United States Of America.

The target audience for this medical event for directed toward pathologists and oncologists interested in the management of patients with cancer. Fellows, residents, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of patients with cancer are also invited to attend. This CME Conference has been approved with a maximum of 7.25 AMA PRA Category 1 Credits.

Overview :
This course will provide the latest information on key topics in pathology that can readily be applied to clinical practice in a variety of settings. This event will bring together oncologists and pathologists to facilitate awareness of recent advancements in the field of cancer pathology and enhance multidisciplinary collaboration. Leading experts will address critical topics in pathology screening for malignancies commonly encountered in clinical practice. From a foundation of tumor-specific discussions, our clinical experts will appraise clinical guidelines, explore new concepts and clinical research, and address obstacles to optimizing practice. This will be a dynamic experience, allowing participants to engage with faculty as they share their perspectives and personal experiences on clinical challenges and ongoing controversies in the field of pathology. A variety of formats will be used to generate an exciting learning environment, including cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions.

Conference Objectives are :
Upon completion of this activity, participants should have improved their ability to :
• Describe recent advancements in the understanding of the pathogenesis and relevant biomarkers of commonly-encountered malignancies.
• Select evidence-based molecular and cytogenetic testing strategies for commonly-encountered malignancies.
• Compare the roles of genomic and targeted assays in patient management.
• Develop multidisciplinary strategies to optimize cancer diagnosis and management.
• Apply current clinical trial data in cancer pathology to the tailoring of patient treatment protocols.

Additional details will be posted as soon as they are available.